NEW YORK (360Dx) – Grifols said today that it has inked an exclusive, long-term agreement with Beckman Coulter for the global distribution of Grifols' hemostasis instruments, reagents, and consumables.

The firms expect that under the distribution agreement, the first commercial systems will be available in Europe in early 2018.

Additional terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.